TITLE

Pseudoxanthoma elasticum-like skin changes induced by penicillamine

AUTHOR(S)
Bentley-Phillips, Barry
PUB. DATE
September 1985
SOURCE
Journal of the Royal Society of Medicine;Sep1985, Vol. 78 Issue 9, p787
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to a report by Meyrick Thomas regarding the side effects of penicillamine to a male patient suffering from cystinuria in the September 1984 issue.
ACCESSION #
22799182

 

Related Articles

  • Effect of oral iron on penicillamine absorption. Lyle, W. H. // Journal of the Royal Society of Medicine;Jan1988, Vol. 81 Issue 1, p58 

    A letter to the editor is presented about the effects of oral iron on the absorption of penicillamine.

  • The Mechanisms of Penicillamine, Trientine, and Zinc in the Treatment of Wilson's Disease. Yarze, Joseph Carl // American Journal of Gastroenterology;Jun1995, Vol. 90 Issue 6, p1026 

    Presents a letter to the editor in response to the article "Penicillamine Hypersensitivity: Successful De-sensitization of a Patient With Severe Hepatic Wilson's Disease," by C.-Y. Chan and A. L. Baker," in the 1994 issue.

  • Mechanisms of Pennicillamine and Zinc in the Treatment of Wilson's Disease. Farinati, F.; Cardin, R.; Mestriner, C.; Sturniolo, G. C.; Naecarato, R. // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2264 

    Presents letters to the editor referencing articles and topics discussed in previous issues. "Penicillamine Hypersensitivity: Successful Desensitization of Patients With Severe Hepatic Wilson's Disease," which examined hepatic Wilson's disease; "The Mechanisms of Penicillamine, Trientine, and...

  • Penicillamine-induced neuromyotonia. Reeback, Jane; Benton, Sarah; Swash, Michael; Schwartz, Martin S. // British Medical Journal;6/2/1979, Vol. 1 Issue 6176, p1464 

    Presents a case report on penicillamine-induced neuromyotonia. Treatment of rheumatoid arthritis with penicillamine; Association penicillamine treatment of rheumatoid arthritis with polymitosis and myasthenia gravis; Pathogenesis of neuromyotonia.

  • Exacerbation of diazepam-induced phlebitis by oral penicillamine. Brandstetter, Robert D.; Gotz, Vincent P.; Mar, Dexter D.; Sachs, Deane // British Medical Journal (Clinical Research Edition);8/22/1981, Vol. 283 Issue 6290, p525 

    Examines the oral penicillamine in patients with phlebitis in Great Britain. Severity of the reactions to the drug; Toxicity for patients with rheumatoid arthritis; Development of phlebitis from intravenous diazepam.

  • Natural course of penicillamine nephropathy: a long term study of 33 patients. Hall, C.L.; Jawad, S.; Harrison, P.R.; MacKenzie, J.C.; Bacon, P.A.; Klouda, P.T.; MacIver, A.G. // British Medical Journal (Clinical Research Edition);4/16/1988, Vol. 296 Issue 6629, p1083 

    Examines the natural course of the neuropathy associated with penicillamine and the clinical management of patients with rheumatoid arthritis. Conduction of renal biopsies; Measurement of creatinine clearance and proteinuria; Implication of penicillamine treatment for the resolution of the...

  • Penicillamine nephropathy.  // British Medical Journal (Clinical Research Edition);3/7/1981, Vol. 282 Issue 6266, p761 

    Examines the occurence of proteinuria due ti treatment with penicillamine. Comparisons on the occurence of proteinuria in patients with rheumatoid arthritis and Wilson's diseases; Indication of minimal changes according to the histological examination of renal biopsy specimens from affected...

  • Penicillamine-Induced Neuropathy in Rheumatoid Arthritis. Pool, K.D.; Feit, Howard; Kirkpatrick, Joel // Annals of Internal Medicine;Oct81, Vol. 95 Issue 4, p457 

    Presents a case of penicillamine-induced neuropathy in rheumatoid arthritis. Indication of penicillamine in rheumatoid arthritis; Case report on the patient; Discussion on the clinical findings.

  • The toxicity of D-penicillamine in systemic sclerosis. Steen, Virginia D.; Blair, Sandra; Medsger Jr., Thomas A.; Steen, V D; Blair, S; Medsger, T A Jr // Annals of Internal Medicine;May86, Vol. 104 Issue 5, p699 

    We studied D-penicillamine toxicity in 259 patients with systemic sclerosis treated since 1972. The average daily dose of 635 mg was given for a mean of 1.8 years. Of patients with systemic sclerosis, 47% has side effects from D-penicillamine treatment, similar to the 56% of 807 patients with...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics